苏州特瑞药业

Suzhou T-Ray Pharmaceutical is a China-based pharmaceutical company focused on the development and commercialization of high-barrier generic drugs and innovative small molecule therapeutics. Established in 2010, the company has built a robust portfolio targeting oncology, hematology, cardiovascular, and central nervous system indications. T-Ray operates integrated facilities that include advanced R&D centers and GMP-compliant manufacturing plants for both active pharmaceutical ingredients (APIs) and finished dosage forms. The company is recognized for its expertise in complex chemical synthesis and its ability to bring difficult-to-manufacture generics to the global market. T-Ray continues to expand its pipeline through internal innovation and strategic partnerships, aiming to provide affordable, high-quality medicine to patients worldwide.